EUS-guided paclitaxel injection as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation before surgery for localized or locoregional esophageal cancer: a multicenter prospective randomized trial
Authors:
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 86 (1) , 140-149
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyGastrointestinal Endoscopy, 2012
- Endoscopic and Surgical Treatment of Mucosal (T1a) Esophageal Adenocarcinoma in Barrett's EsophagusGastroenterology, 2009
- Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancerAnti-Cancer Drugs, 2009
- Phase 1 study of escalating-dose OncoGel® (ReGel®/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesionsAnti-Cancer Drugs, 2007
- A survey of oesophageal cancer: pathology, stage and clinical presentationAlimentary Pharmacology & Therapeutics, 2006
- Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysisGut, 2004
- Esophageal CancerNew England Journal of Medicine, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Taxol-Induced Soft-Tissue Injury Secondary to Extravasation: Characterization by Histopathology and Clinical CourseJNCI: Journal of the National Cancer Institute, 1994
- Taxol: A novel radiation sensitizerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992